Hide this
 

Could a Generic Zocor ''Hurt'' The Statin Market?

January 17, 2006 | 9,021 views

A generic version of Zocor, the second best selling drug in the U.S., could result in consumers paying a good deal less for cholesterol pills. Zocor loses its patent protections in June, meaning a cheaper generic copy of the currently pricey drug may soon be available.

"Pretty Much Interchangeable"

Zocor, Lipitor, and other cholesterol drugs are likely to experience lessened sales as a result.

Lipitor, Zocor, Crestor, and other drugs in the "statin" class have been judged by many experts to be "pretty much interchangeable", so patients are likely to be pushed by insurance companies to use the less expensive generic brands when they are available.

Broad Medicare Drug Benefit

At the same time, Medicare is offering a broad drug benefit for the first time, increasing the probability that many seniors will be encouraged to shift to the cheapest possible version.

However, manufacturers of brand-name statin drugs say they believe doctors and patients will stick to their products, arguing that their brands are in fact superior.

 

 

Dr. Mercola's Comments:

 

 

I recently ran a story  about Pfizer dodging a bullet when its cash cow, Lipitor, was protected from the generic drug market for five more years by a federal judge.

But this astute look at the multi-national pharmaceutical landscape in the Chicago Tribune shows how the soon-to-be-generic status of another statin drug -- Zocor -- will be a boon to the conventional drug paradigm at the end of the day.

With Zocor moving to generic status in June, this statin will cost close to half as much ($2 a pill) at the retail level. And the fact that one statin isn't any better than any other (except, perhaps, some are more dangerous), combined with the looming disaster that is the Medicare drug benefit package, gives a generic Zocor product a huge marketing advantage.

Statin drugs are one of the most unnecessary drugs in medicine. There are a small group of people with genetic enzyme defects that have cholesterols levels above 325-350. These are about the only individuals in my experience, who seem to benefit from statins. In my practice of 10,000 patients there has been a grand total of three patients that required statins to control this genetic problem.

Just about every other person can normalize their cholesterol levels with the Total Health Program. What is really disturbing though is that the standard of care in conventional medicine seems to have evolved into physicians prescribing these drugs for anyone with a heart attack on these dangerous drugs. Even if their cholesterol level is already dangerously low (below 150). 

What nearly all conventional physicians fail to appreciate is that there is a danger of having a cholesterol that is too low.

So avoid statin drug deception -- inexpensive generic or not -- without taking one by making simple lifestyle changes which include modifying your eating habits based on your body's unique nutritional type.

If you truly want to normalize your cholesterol levels:

 

 


[+] Sources and References
  • Chicago Tribune December 29, 2005 Registration Required

Thank you! Your purchases help us support these charities and organizations.